National Audit of Criteria For Pre-Operative Sickle Cell Screening in Children

Ir Med J. 2022 Aug 18;115(7):631.

Abstract

Aim We set out to identify the current practice in the anaesthesiology departments of Ireland's public hospitals that deliver paediatric anaesthesia with regard to pre-operative screening for sickle cell disease (SCD) and Sickle cell trait (SCT). Methods The Departments of Anaesthesiology at 14 public HSE-funded hospitals that deliver paediatric anaesthesia were contacted over a three month period in 2020. Any existing policies regarding pre-operative screening of paediatric patients for Sickle cell disease or trait were sought. Comparisons were made between any screening policies in place. Results A response was received from 11 of the 14 hospitals. Three out of 11 of the Anaesthesiology Departments have formal policies in place. The ethnicities identified for pre-operative screening varied across these three hospitals. Conclusion Despite a significant increase in the number of people of African, middle Eastern & Indian descent living in Ireland in recent years, no neonatal screening programme for Sickle cell exists here, and no national policy exists with criteria to guide the practice of pre-operative screening of patients for SCD/SCT (trait). Our survey highlights a lack of standardisation in the approach to pre-operative sickle cell screening of children across Ireland's public hospital system. In view of the increasing multiculturalism in Ireland we recommend a national review of the merits of the introduction of developing a targeted national guideline for pre-operative screening for sickle cell in at-risk children.

Keywords: Sickle Cell Screening.

MeSH terms

  • Anemia, Sickle Cell* / diagnosis
  • Anemia, Sickle Cell* / prevention & control
  • Child
  • Hematologic Tests
  • Humans
  • Infant, Newborn
  • Neonatal Screening / methods
  • Phenotype
  • Sickle Cell Trait* / diagnosis
  • Sickle Cell Trait* / prevention & control